Sorrento Therapeutics, Inc. SC 13D and SC 13D/A reports

Location
4955 Directors Place, San Diego, CA
State of incorporation
DE
Fiscal year end
December 31
Data updated at
7/19/2024, 08:55 AM
Form type Sec Links Description Filing date Reporting date
SC 13D/A Report SC 13D/A Sep 26, 2023
SC 13D/A Report SC 13D/A Aug 15, 2023
SC 13D/A Report SC 13D/A Mar 3, 2023
SC 13D/A Report SC 13D/A Jan 23, 2023
SC 13D Report SC 13D Nov 17, 2022
SC 13D Report SC 13D May 9, 2019
SC 13D/A Report SC 13D/A Feb 8, 2018
SC 13D Report SC 13D Jul 10, 2017
SC 13D/A Report SC 13D/A Jul 11, 2016
SC 13D/A Report SC 13D/A Jun 28, 2016
SC 13D/A Report Jun 22, 2016
SC 13D/A Report Jun 2, 2016
SC 13D/A Report | Data May 16, 2016
SC 13D/A Report May 11, 2016
SC 13D/A Report May 6, 2016
SC 13D/A Report Apr 26, 2016
SC 13D Report Apr 18, 2016
SC 13D/A Report SC 13D/A Dec 21, 2015
SC 13D Report SC 13D Dec 24, 2014
SC 13D/A Report SC 13D/A Mar 11, 2014
SC 13D/A Report SC 13D/A Jan 7, 2014
SC 13D/A Report SC 13D/A Apr 25, 2013
SC 13D/A Report SC 13D/A Sep 13, 2012
SC 13D/A Report SCHEDULE 13D/A Aug 23, 2012
SC 13D/A Report SCHEDULE 13D/A May 25, 2012
SC 13D/A Report SCHEDULE 13D AMENDMENT NO. 1 Jan 26, 2011